Hutubessy RC - Search Results

1

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HA, Hutubessy RC. Postma MJ, et al. Among authors: hutubessy rc. BMC Med. 2011 Jul 8;9:84. doi: 10.1186/1741-7015-9-84. BMC Med. 2011. PMID: 21740545 Free PMC article. Review.

2

The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia.

Setiawan D, Annisa AN, Lianawati, Hutubessy RCW, Ting Yeung KH. Setiawan D, et al. Among authors: hutubessy rcw. Value Health Reg Issues. 2023 May;35:102-108. doi: 10.1016/j.vhri.2023.01.005. Epub 2023 Mar 17. Value Health Reg Issues. 2023. PMID: 36934486 Free article.

3

Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania.

Hsiao A, Struckmann V, Stephani V, Mmbando D, Changalucha J, Baisley K, Levin A, Morgan W, Hutubessy R, Watson-Jones D, Whitworth H, Quentin W. Hsiao A, et al. Vaccine. 2023 Jan 9;41(2):372-379. doi: 10.1016/j.vaccine.2022.11.032. Epub 2022 Nov 29. Vaccine. 2023. PMID: 36460537 Free PMC article.

4

Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review.

Patikorn C, Cho JY, Lambach P, Hutubessy R, Chaiyakunapruk N. Patikorn C, et al. Vaccines (Basel). 2023 Mar 9;11(3):622. doi: 10.3390/vaccines11030622. Vaccines (Basel). 2023. PMID: 36992206 Free PMC article. Review.

5

Modeling anticipated changes in numbers of SARS-CoV-2 infections within communities due to immunization campaigns.

Frey K, Hagedorn B, McCarthy KA, Hutubessy R, Wang SA. Frey K, et al. Gates Open Res. 2022 Sep 27;6:7. doi: 10.12688/gatesopenres.13448.2. eCollection 2022. Gates Open Res. 2022. PMID: 36299735 Free PMC article.

6

Systematic review of cost projections of new vaccine introduction.

Levin A, Yeung KHT, Hutubessy R. Levin A, et al. Vaccine. 2024 Feb 15;42(5):1042-1050. doi: 10.1016/j.vaccine.2024.01.024. Epub 2024 Jan 25. Vaccine. 2024. PMID: 38278630 Free PMC article. Review.

7

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools.

Chaiyakunapruk N, Somkrua R, Hutubessy R, Henao AM, Hombach J, Melegaro A, Edmunds JW, Beutels P. Chaiyakunapruk N, et al. BMC Med. 2011 May 12;9:53. doi: 10.1186/1741-7015-9-53. BMC Med. 2011. PMID: 21569402 Free PMC article.

8

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R. Jit M, et al. BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.

9

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Hutubessy R, Henao AM, Namgyal P, Moorthy V, Hombach J. Hutubessy R, et al. BMC Med. 2011 May 12;9:55. doi: 10.1186/1741-7015-9-55. BMC Med. 2011. PMID: 21569407 Free PMC article.

10

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Deogaonkar R, et al. BMC Public Health. 2012 Oct 16;12:878. doi: 10.1186/1471-2458-12-878. BMC Public Health. 2012. PMID: 23072714 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters